These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 23886968)

  • 1. Flu vaccinations for school age children in England are cost effective, say experts.
    Iacobucci G
    BMJ; 2013 Jul; 347():f4749. PubMed ID: 23886968
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccinating healthy children against flu is cost effective, says committee.
    Murphy H
    BMJ; 2012 Jun; 344():e3876. PubMed ID: 22661740
    [No Abstract]   [Full Text] [Related]  

  • 3. Benefits and costs of immunizing children against influenza at school: an economic analysis based on a large-cluster controlled clinical trial.
    Schmier J; Li S; King JC; Nichol K; Mahadevia PJ
    Health Aff (Millwood); 2008; 27(2):w96-104. PubMed ID: 18216044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The National Board of Health and Welfare has the last word].
    Lindberg A; Möllergren M; Tegnell A
    Lakartidningen; 2008 May 28-Jun 3; 105(22):1685-7. PubMed ID: 18590012
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil.
    Valentim J; Sartori AM; de Soárez PC; Amaku M; Azevedo RS; Novaes HM
    Vaccine; 2008 Nov; 26(49):6281-91. PubMed ID: 18674582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-benefit comparisons of investments in improved water supply and cholera vaccination programs.
    Jeuland M; Whittington D
    Vaccine; 2009 May; 27(23):3109-20. PubMed ID: 19428925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
    Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
    Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of varicella serotesting versus presumptive vaccination of school-age children and adolescents.
    Lieu TA; Finkler LJ; Sorel ME; Black SB; Shinefield HR
    Pediatrics; 1995 May; 95(5):632-8. PubMed ID: 7724297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunisation rates of routine vaccinations for school starters as a quantitative measure in the vaccination behaviour].
    Stich HL; Beblo F
    Gesundheitswesen; 2001 Dec; 63(12):748-54. PubMed ID: 11735067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningococcal C vaccines: the Canadian experience.
    De Wals P
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the recommendations for annual influenza vaccination to school-age children in the United States.
    Fiore AE; Epperson S; Perrotta D; Bernstein H; Neuzil K
    Pediatrics; 2012 Mar; 129 Suppl 2():S54-62. PubMed ID: 22383482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urban middle school parent perspectives: the vaccines they are willing to have their children receive using school-based immunization programs.
    Middleman AB; Tung JS
    J Adolesc Health; 2010 Sep; 47(3):249-53. PubMed ID: 20708563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful use of volunteers to conduct school-located mass influenza vaccination clinics.
    Cummings GE; Ruff E; Guthrie SH; Hoffmaster MA; Leitch LL; King JC
    Pediatrics; 2012 Mar; 129 Suppl 2():S88-95. PubMed ID: 22383487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of delivering child immunization services in urban Bangladesh: a study based on facility-level surveys.
    Khan MM; Khan SH; Walker D; Fox-Rushby J; Cutts F; Akramuzzaman SM
    J Health Popul Nutr; 2004 Dec; 22(4):404-12. PubMed ID: 15663173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Universal mass vaccination against varicella in Germany using an MMRV combination vaccine with a two-dose schedule: an economic analysis.
    Hammerschmidt T; Bisanz H; Wutzler P
    Vaccine; 2007 Oct; 25(42):7307-12. PubMed ID: 17881097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicaid-based child restraint system disbursement and education and the vaccines for children program: comparative cost-effectiveness.
    Goldstein JA; Winston FK; Kallan MJ; Branas CC; Schwartz JS
    Ambul Pediatr; 2008; 8(1):58-65. PubMed ID: 18191783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. School-located vaccination clinics: then and now.
    Mazyck D
    J Sch Nurs; 2010 Aug; 26(4 Suppl):3S-6S. PubMed ID: 20410289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost-effectiveness analysis of universal versus selective immunization with Mycobacterium bovis bacille Calmette-Guérin in Finland.
    Hersh AL; Tala-Heikkilä M; Tala E; Tosteson AN; Fordham von Reyn C
    Int J Tuberc Lung Dis; 2003 Jan; 7(1):22-9. PubMed ID: 12701831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost of epidemiological transition: a study of a decrease in pertussis vaccination coverage.
    Girard DZ
    Health Policy; 2005 Nov; 74(3):287-303. PubMed ID: 15951048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GAVI gears up for record replenishment.
    Usher AD
    Lancet; 2014 Jul; 384(9939):219-20. PubMed ID: 25050437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.